Insight Genetics Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$12M
Insight Genetics General Information
Description
Provider of diagnostic services dedicated to improving the lives of cancer patients through advanced molecular diagnostics. The company specializes in the discovery, development and commercialization of molecular diagnostics that detect specific cancer biomarkers in triple negative breast cancer and lung cancer to assist in guiding the effective diagnosis, treatment and monitoring of cancer, enabling medical practitioners to provide precision cancer care.
Contact Information
Website
www.insightgenetics.comCorporate Office
- 2 International Plaza Drive
- Suite 510
- Nashville, TN 37217
- United States
Corporate Office
- 2 International Plaza Drive
- Suite 510
- Nashville, TN 37217
- United States
Insight Genetics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 31-Jan-2020 | $12M | Completed | Generating Revenue | ||
4. Seed Round | 06-Nov-2015 | Completed | Generating Revenue | |||
3. Grant | 06-Jan-2014 | Completed | Generating Revenue | |||
2. Grant | 27-Aug-2013 | $1.5M | Completed | Generating Revenue | ||
1. Grant | 06-Oct-2011 | $193K | Completed | Startup |
Insight Genetics Comparisons
Industry
Financing
Details
Insight Genetics Competitors (32)
One of Insight Genetics’s 32 competitors is Monopar Therapeutics, a Formerly VC-backed company based in Wilmette, IL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Monopar Therapeutics | Formerly VC-backed | Wilmette, IL | ||||
Beactica Therapeutics | Venture Capital-Backed | Uppsala, Sweden | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Aro Biotherapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
Xenetic Bioscience | Corporation | Framingham, MA |
Insight Genetics Patents
Insight Genetics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3137630-A4 | Methods and compositions relating to fusions of alk for diagnosing and treating cancer | Inactive | 28-Apr-2014 | ||
US-20150307944-A1 | Kit comprising primers for amplifying alk kinase domain nucleic acids | Active | 28-Apr-2014 | ||
EP-3137630-A2 | Methods and compositions relating to fusions of alk for diagnosing and treating cancer | Inactive | 28-Apr-2014 | ||
US-9428812-B2 | Kit comprising primers for amplifying alk kinase domain nucleic acids | Inactive | 28-Apr-2014 | ||
US-20150240301-A1 | Methods and compositions relating to next generation sequencing for genetic testing in alk related cancers | Inactive | 05-Oct-2012 | C12Q1/6874 |
Insight Genetics Signals
Insight Genetics Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Cancer Institute | Government |
Insight Genetics FAQs
-
When was Insight Genetics founded?
Insight Genetics was founded in 2007.
-
Where is Insight Genetics headquartered?
Insight Genetics is headquartered in Nashville, TN.
-
What is the size of Insight Genetics?
Insight Genetics has 20 total employees.
-
What industry is Insight Genetics in?
Insight Genetics’s primary industry is Biotechnology.
-
Is Insight Genetics a private or public company?
Insight Genetics is a Private company.
-
What is the current valuation of Insight Genetics?
The current valuation of Insight Genetics is
. -
What is Insight Genetics’s current revenue?
The current revenue for Insight Genetics is
. -
How much funding has Insight Genetics raised over time?
Insight Genetics has raised $3.05M.
-
Who are Insight Genetics’s investors?
National Cancer Institute has invested in Insight Genetics.
-
Who are Insight Genetics’s competitors?
Monopar Therapeutics, Beactica Therapeutics, NexImmune, Aro Biotherapeutics, and Xenetic Bioscience are some of the 32 competitors of Insight Genetics.
-
When was Insight Genetics acquired?
Insight Genetics was acquired on 31-Jan-2020.
-
Who acquired Insight Genetics?
Insight Genetics was acquired by OncoCyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »